Cue Biopharma (CUE) News Today → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free CUE Stock Alerts $2.18 +0.10 (+4.81%) (As of 05/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences Conferencefinance.yahoo.com - May 7 at 7:57 PMCue Biopharma, Inc. (NASDAQ:CUE) Short Interest Updatemarketbeat.com - April 30 at 12:46 AMCue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meetingglobenewswire.com - April 24 at 10:01 AMForecasting The Future: 4 Analyst Projections For Cue Biopharmamarkets.businessinsider.com - April 9 at 5:33 PMStifel Nicolaus Reiterates "Buy" Rating for Cue Biopharma (NASDAQ:CUE)marketbeat.com - April 9 at 9:13 AMCue Biopharma, Inc.: Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlightsfinanznachrichten.de - April 9 at 7:33 AMCue Biopharma Inc (CUE) Q4 2023 Earnings Call Transcript Highlights: Strategic Alliances and ...finance.yahoo.com - April 9 at 7:33 AMCue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlightsmarkets.businessinsider.com - April 8 at 6:36 PMCue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlightsglobenewswire.com - April 8 at 4:05 PMOptions Volatility and Implied Earnings Moves Today, April 08, 2024msn.com - April 8 at 1:36 PMCue Biopharma is about to announce earnings — here's what Wall Street expectsmarkets.businessinsider.com - April 7 at 10:48 AMCue Biopharma (NASDAQ:CUE) Receives Overweight Rating from Piper Sandlermarketbeat.com - April 3 at 12:14 PMCUE Stock Earnings: Cue Biopharma Misses EPS, Beats Revenue for Q4 2023investorplace.com - April 2 at 3:02 PMCue Biopharma to Host Business Update Call and Webcastfinance.yahoo.com - April 2 at 1:56 PMCue Biopharma to Host Business Update Call and Webcastfinance.yahoo.com - April 2 at 1:56 PMCarisma to cut 37% of workforce, stock falls 8%msn.com - April 1 at 4:39 PMCue Biopharma (CUE) to Release Quarterly Earnings on Tuesdaymarketbeat.com - March 18 at 7:39 AMWhat 4 Analyst Ratings Have To Say About Silence Therapeuticsmarkets.businessinsider.com - March 13 at 4:51 PMCue Biopharma (NASDAQ:CUE) Coverage Initiated at Jefferies Financial Groupmarketbeat.com - March 13 at 7:32 AMCue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposiumfinance.yahoo.com - February 29 at 12:17 PMCue Biopharma's Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposiumglobenewswire.com - February 29 at 10:00 AMCue Biopharma Inc Ordinary Sharesmorningstar.com - February 27 at 6:51 PMAnalysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Intellia Therapeutics (NTLA) and Cue Biopharma (CUE)markets.businessinsider.com - February 26 at 3:22 PMCue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences Conferencefinance.yahoo.com - February 6 at 12:41 PMCue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences Conferencefinance.yahoo.com - February 6 at 12:41 PMCue Biopharma, Inc. (NASDAQ:CUE) Short Interest Up 6.7% in Januarymarketbeat.com - February 1 at 9:19 AMCue Biopharma (NASDAQ:CUE) investors are sitting on a loss of 80% if they invested three years agofinance.yahoo.com - January 17 at 9:21 AMShort Interest in Cue Biopharma, Inc. (NASDAQ:CUE) Expands By 5.2%marketbeat.com - January 16 at 5:17 AMShort Interest in Cue Biopharma, Inc. (NASDAQ:CUE) Rises By 8.3%marketbeat.com - January 3 at 12:47 PMCUE Stock Earnings: Cue Biopharma Beats EPS, Beats Revenue for Q3 2023investorplace.com - December 14 at 8:04 AMAre Medical Stocks Lagging Corvus Pharmaceuticals (CRVS) This Year?finance.yahoo.com - December 7 at 3:00 PMCue Biopharma to Present at the JMP Securities Hematology and Oncology Summitfinance.yahoo.com - November 22 at 12:52 PMCue Biopharma, Inc. (NASDAQ:CUE) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 12 at 3:16 PMCue Biopharma reports Q3 resultsmsn.com - November 10 at 8:07 AMCue Biopharma Reports Third Quarter 2023 Financial Results and Recent Business Highlightsfinance.yahoo.com - November 10 at 8:07 AMCue Biopharma Reports Third Quarter 2023 Financial Results and Recent Business Highlightsfinance.yahoo.com - November 9 at 8:46 PMCue Biopharma Inc Ordinary Shares CUEmorningstar.com - November 8 at 1:48 AMAnalysts Conflicted on These Healthcare Names: Cue Biopharma (CUE) and Mirati Therapeutics (MRTX)markets.businessinsider.com - November 7 at 3:46 PMCue Biopharma to Present at Three Upcoming Investor Healthcare Conferences in Novemberfinance.yahoo.com - November 7 at 10:20 AMAnalysts Offer Insights on Healthcare Companies: Cue Biopharma (CUE), Zoetis (ZTS) and CymaBay Therapeutics (CBAY)markets.businessinsider.com - November 6 at 11:23 PMCue Biopharma Presents New Positive Data from Phase 1 Trials of CUE-101 in Head and Neck Cancer and CUE-102 in Wilms’ Tumor 1 Positive Cancers at SITC 2023finance.yahoo.com - November 3 at 2:37 PMAcadia (ACAD) Surges 8.3%: Is This an Indication of Further Gains?finance.yahoo.com - September 28 at 11:39 AMCue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meetingfinance.yahoo.com - September 27 at 11:52 AMCue Biopharma, Inc.: Cue Biopharma Announces Completion of Patient Enrollment in Phase 1b Study of CUE-101 in Combination with KEYTRUDAfinanznachrichten.de - September 26 at 5:16 PMCue Biopharma Announces Completion of Patient Enrollment in Phase 1b Study of CUE-101 in Combination with KEYTRUDA®finance.yahoo.com - September 26 at 12:16 PMCue Biopharma And 2 Other Stocks Under $3 Insiders Are Buyingbenzinga.com - August 30 at 4:25 PMCue Biopharma, Inc.: Cue Biopharma Reports Second Quarter 2023 Financial Results and Recent Business Highlightsfinanznachrichten.de - August 12 at 4:40 AMCue Biopharma: Nothing Stands Out For This Cancer Immunotherapy Developermsn.com - August 10 at 11:46 PMInvestors in Cue Biopharma (NASDAQ:CUE) have unfortunately lost 83% over the last three yearsfinance.yahoo.com - August 10 at 12:40 PMCue Biopharma, Inc. (NASDAQ:CUE) Q2 2023 Earnings Call Transcriptfinance.yahoo.com - August 10 at 12:40 PM Get Cue Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CUE and its competitors with MarketBeat's FREE daily newsletter. Email Address AI “wealth window” is closing June 25th (Ad)Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry. I put together this personal video [HERE]… CUE Media Mentions By Week CUE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CUE News Sentiment▼0.000.38▲Average Medical News Sentiment CUE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CUE Articles This Week▼11▲CUE Articles Average Week Get Cue Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CUE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: OptiNose News PMV Pharmaceuticals News Allakos News BioXcel Therapeutics News Oramed Pharmaceuticals News Clearside Biomedical News Anixa Biosciences News Eton Pharmaceuticals News IO Biotech News Hookipa Pharma News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CUE) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorGold Set to EXPLODE!Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI “wealth window” is closing June 25thParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsStock-Picking AI Predicts #1 Stock of 2024AltimetryElon Musk Secret Crypto Plot ExposedCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cue Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
